Giant Biogene Holding Co Ltd (2367): Gewinn- und Verlustrechnung
| Preis (11.09.2026) | 52W Hoch | 52W Tief |
| 25,48 Hongkong Dollar | 62,616 Hongkong Dollar | 24,2 Hongkong Dollar |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 37,401 Hongkong Dollar | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 1.061.704.000 | - | - |
Kennzahl in 1000 CNY | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|---|---|
Umsatz | 5.518.512 | 5.538.812 | 3.524.143 | 2.364.445 | 1.552.486 | 1.190.479 | 956.702 |
Herstellungskosten | 1.085.162 | 991.897 | 577.006 | 369.205 | 198.149 | 183.409 | 159.990 |
Bruttoergebnis | 4.433.350 | 4.546.915 | 2.947.137 | 1.995.240 | 1.354.337 | 1.007.070 | 796.712 |
▸ Brutto-Marge | 80,34% | 82,09% | 83,63% | 84,39% | 87,24% | 84,59% | 83,28% |
Betriebliche Aufwendungen | 2.312.567 | 2.238.283 | 1.282.264 | 862.100 | 439.771 | 200.316 | 108.068 |
Operativer Gewinn/Verlust | 2.120.783 | 2.308.632 | 1.664.873 | 1.133.140 | 914.566 | 806.754 | 688.644 |
▸ Operative Marge | 38,43% | 41,68% | 47,24% | 47,92% | 58,91% | 67,77% | 71,98% |
Zinsen (Netto) | 8.891 | 3.601 | - | - | -36.080 | -154.778 | - |
▸ Zinsausgaben | 302 | 239 | 112 | 21 | 45.488 | 164.660 | - |
▸ Zinseinnahmen | 9.193 | 3.840 | 112 | 21 | 9.408 | 9.882 | - |
Andere Ausgaben | -220.630 | -145.521 | -80.216 | -44.609 | -94.431 | -321.266 | 11.648 |
Gewinn vor Steuern | 2.350.304 | 2.457.754 | 1.745.089 | 1.177.749 | 972.917 | 973.242 | 676.996 |
Steueraufwand | 435.642 | 396.027 | 296.887 | 176.163 | 144.785 | 146.757 | 101.816 |
Minderheitenanteil | -174 | -620 | -3.551 | -439 | - | 35 | 22.920 |
Nettogewinn/-verlust | 1.914.836 | 2.062.347 | 1.451.753 | 1.002.025 | 828.132 | 826.450 | 552.260 |
▸ Netto-Marge | 34,7% | 37,23% | 41,19% | 42,38% | 53,34% | 69,42% | 57,73% |
Kennzahlen dieser Seite im Lexikon
Weitere Informationen findest du im Takani-Lexikon.